Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Flexibility keeps budgets resilient. Explore techniques to flex categories, set automatic rebalances, and protect core priorities.
18,624 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A notable fund sold a sizable stake in a leading pet-food company, triggering questions about motive, timing, and imp...
The U.S. won hosting rights for the 2026 World Cup, but aging infrastructure could strain wallets of travelers and re...
A Texas primary shock sends markets into a risk-off mode as sen. john cornyn becomes a flashpoint for party fault lin...
Choosing when to claim Social Security is tough for couples. This guide breaks down the reasons to delay, the tradeof...
American Superconductor surprised on the top line but traded lower as short-sellers reared their heads. This article ...
NVDY's option-income approach pays steady income but caps upside, leading nvdy investors to miss half of NVIDIA's exp...
A divorced retiree learns, at age 64, that she can claim up to 50% of her ex-spouse's Social Security record, lifting...
The White House has tapped a real-estate heir as acting director of national intelligence, a move that drew sharp que...
SpaceX aims for the largest IPO in history, targeting a $135-per-share price and up to $75 billion in proceeds. Durin...
Missed the AI rally? Reasons watch MercadoLibre now. This guide breaks down three actionable catalysts, real-world sc...
As U.S. bond markets stabilize in 2026, investors compare BND and AGG for broad fixed-income exposure. Both funds tra...